Because patients from the RA group were treated with various drugs, we can conclude that medicines, regardless of their main mechanism of action, may have an influence on PADI4 methylation or that the efficacy of treatment may even depend on the final hyper-methylation of this DNA region. The gene discussed is PADI4; the disease is rheumatoid arthritis.